New insider activity at Crescent Capital BDC ( (CCAP) ) has taken place on May 21, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Crescent Capital BDC has seen fresh insider confidence as CEO Jason Breaux purchased 5,000 shares of the company’s stock, in a transaction valued at $55,950. This insider buy signals a notable show of trust from top leadership in the company’s prospects.
Recent Updates on CCAP stock
Crescent Capital BDC shares reflected a mixed Q1 backdrop, as analysts highlighted structural positives but trimmed expectations amid credit and earnings pressure. Fee cuts and a reset dividend are viewed as long‑term supportive, yet rising nonaccruals, NAV decline, yield compression, and refinancing needs led to lower earnings estimates and reduced price targets.
Spark’s Take on CCAP Stock
According to Spark, TipRanks’ AI Analyst, CCAP is a Neutral.
The score is anchored by decent underlying fundamentals with strong cash conversion but tempered by leverage and uneven growth. Technicals are a major drag as the stock sits below all key moving averages with bearish momentum despite being oversold. Valuation is mixed: a very high yield is supportive, but the negative P/E reflects elevated earnings uncertainty, and the latest earnings call highlighted credit pressure (higher nonaccruals), weaker NII, and a NAV decline alongside stabilizing strategic actions.
To see Spark’s full report on CCAP stock, click here.
More about Crescent Capital BDC
YTD Price Performance: -16.73%
Average Trading Volume: 229,695
Technical Sentiment Signal: Sell
Current Market Cap: $416.4M